Tender germany - open house discount drug-5539983

This tender with title Germany - Open house discount drug contracts tamsulosin and dutasteride, ATC G04CA52 --
Open house Arzneimittelrabattverträge Tamsulosin und Dutasterid, ATC G04CA52 has been published on Bidding Source portal dated 23 Apr 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Open house Arzneimittelrabattverträge Tamsulosin und Dutasterid, ATC G04CA52

General Information

Germany

Tender Title :

Germany - Open house discount drug contracts tamsulosin and dutasteride, ATC G04CA52

Open house Arzneimittelrabattverträge Tamsulosin und Dutasterid, ATC G04CA52

Tender Type :

Invitation for Bids

Reference No. :

2023/S 077-233100

Country :

Germany

Province/City :

Germany-Munich

Publish Date :

23 Apr 2023

Closing Date :

5 Apr 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

336062- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-17 -Agalsidase beta Germany 330350- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient fusidic acid/betamethasone (ATC code according to WHO: D07CC01) Germany 332579- Germany – Pharmaceutical products – Open House Original Discount Agreements 2025-17 - Beclometasone, Formoterol, Glycopyrronium (active ingredient combination) ATC: R03AL09 Germany 329876- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Vedolizumab, ATC L04AG05 for the period 01.07.2025 - 30.06.2027 Germany 332682- Germany – Pharmaceutical products – Open-house drug discount contracts pursuant to Section 130a, Paragraph 8c of the Social Code Book V for the KV region of Mecklenburg-Vorpommern Germany 332570- Germany – Pharmaceutical products – Open-house drug discount contracts pursuant to Section 130a Paragraph 8c SGB V for the KV region of Brandenburg Germany 331858-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and ViiV Healthcare GmbH for Rekambys(R) Germany 324018- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient epinephrine, ATC C01CA24, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). Germany 323156- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient carglumic acid, ATC A16AA05, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). Germany 322835- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient lenalidomide, ATC L04AX04, for the period from July 1, 2025, to June 30, 2027 (plus an extension option of 12 months). Germany

Germany - Open house discount drug contracts tamsulosin and dutasteride, ATC G04CA52

Open house Arzneimittelrabattverträge Tamsulosin und Dutasterid, ATC G04CA52

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com